Skip to content
BizDaily AE delivers up-to-date business news, financial an…

The Zimbabwean Government Declines ‘Unbalanced’ US Health Aid Deal Due to Information Apprehensions

Medical aid illustration
The offered US funding would have supported programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

The nation of Zimbabwe has turned down a significant American healthcare agreement valued at $367m (272 million pounds) over five years over Washington's demand for confidential information.

This rejection came to light following a official document dated December was leaked, which showed Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".

An official spokesperson has since clarified that the United States was seeking genetic material for scientific study and commercial gain but refused to share the resulting advantages from any future vaccines.

"We will now turn to the difficult and regrettable process of ending our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

The US Embassy said the US had furnished over $1.9bn for health programmes to Zimbabwe during the past two decades.

A medical body in Zimbabwe has called for more negotiations to secure a deal suitable to both sides so the country's critical HIV treatment initiative can continue.

Broader Implications

Zimbabwe's decision follows a similar case in Kenya, where a court suspended a similar health funding agreement after legal challenges were raised about the safety of citizens' health data.

Since returning to office last year, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.

The agency had administered aid for the American government, but Trump argued its spending was "inefficient" and his administration was pursuing direct bilateral agreements to boost openness and responsibility.

Based on reports, Sixteen African countries have so far signed these new health pacts, constituting over $18.3bn in committed funds.

Specifics of the Declined Deal

The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this cooperation might have yielded extraordinary advantages for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy via American-funded programmes," Tremont commented.

However, government spokesperson Nick Mangwana argued the arrangement was "unequal".

"Our nation was requested to provide its biological resources and data over an extended period, without any corresponding promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.

"In essence, our nation would supply the basic resources for medical research without any certainty that the final treatments would be available to our people if a new pandemic emerge."

National Interest and International Frameworks

He also noted that the US's withdrawal from the global health body and its pursuit of one-on-one deals were disrupting frameworks previously established through the global health agency.

Mangwana cited its Pandemic Benefit-Sharing scheme created to deal with potential pandemics.

"This mechanism is intended to guarantee that when a nation contributes its data, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the funds to create them."

These objections over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.

"We encourage continued discussions with our US partners on how future collaboration might be arranged in a way that respects the independence and dignity of each country."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but suggested that negotiations should continue given that much of the nation's HIV programmes were funded by foreign aid.

"Where technical issues exist, including those involving information security or implementation frameworks, these can often be addressed via detailed discussion and negotiated safeguards," the group added.

The halted deal highlights the continuing tensions between receiving crucial foreign assistance and protecting a country's data in an ever more data-driven world.

The writer

Joseph Bailey

Rashid Al-Mansoori is a seasoned business journalist with over a decade of experience covering Middle Eastern markets and economic developments.

BizDaily AE

Type to search articles.